NASDAQ$MMSI
Merit Medical Systems Inc · Q2 2020 earnings
Q2 2020 earnings · · Investor relations
Briefing
Merit Medical experienced a revenue decline but demonstrated progress in strategic goals and free cash flow generation.
Merit Medical reported a decrease in revenue for Q2 2020, with a worldwide revenue of $218.4 million, a (14.5)% decrease compared to Q2 2019. The company reported a GAAP loss per share of $(0.34) and a non-GAAP EPS of $0.31. Despite the revenue decline, the company generated $32 million in free cash flow and continued progress on strategic goals.
- Worldwide revenue decreased by (14.5)% to $218.4 million compared to Q2 2019.
- Core revenue on a constant currency basis decreased by (13.6)% compared to Q2 2019.
- GAAP loss per share was $(0.34), compared to GAAP EPS of $0.12 in Q2 2019.
- Non-GAAP EPS was $0.31, compared to $0.42 in Q2 2019.
Headline financials
Revenue & EPS history
Merit Medical · Revenue · Quarterly
$218M
Revenue by segment
Merit Medical · $6.19M total across 1 segment · Q2 2020
- Endoscopy$6.19M-30.1%100.0%
Forward guidance
Due to the general uncertainty and rapidly changing global environment related to the COVID-19 pandemic and corresponding economic downturn, Merit’s management has concluded that it cannot issue financial guidance for the remainder of 2020.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2020
-0.1%
Avg return
Earnings day
-0.3%
Avg return
5 days after
+1.8%
Avg return
30 days after
52%
34 / 65 earnings
Positive
+16.5%
Q3 2014
Best reaction
-31.4%
Q3 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +5.2% | -6.8% | -2.8% | |
| Q4 2025 | -3.8% | -7.2% | -16.6% | |
| Q3 2025 | +5.1% | +4.9% | +4.3% | |
| Q1 2025 | -0.1% | -0.2% | +0.7% | |
| Q4 2024 | -1.5% | +1.0% | +1.9% | |
| Q3 2024 | +2.9% | +3.3% | +8.3% | |
| Q2 2024 | +4.0% | +5.0% | +13.4% | |
| Q1 2024 | +2.1% | +5.2% | +7.8% | |
| Q4 2023 | -5.3% | -4.9% | -5.9% | |
| Q3 2023 | +7.7% | +7.3% | +12.9% | |
| Q2 2023 | -9.6% | -8.3% | -16.4% | |
| Q1 2023 | +4.7% | +5.1% | +4.3% | |
| Q4 2022 | +2.8% | +1.3% | +3.7% | |
| Q3 2022 | +7.0% | +14.6% | +19.6% | |
| Q2 2022 | +6.0% | +10.6% | +10.0% | |
| Q1 2022 | -3.7% | -4.7% | -5.2% | |
| Q4 2021 | +8.4% | +9.3% | +5.0% | |
| Q3 2021 | -1.8% | -5.1% | -3.5% | |
| Q2 2021 | +7.6% | +3.9% | +10.1% | |
| Q1 2021 | -0.2% | +1.4% | -5.3% | |
| Q4 2020 | -1.8% | -0.4% | +1.9% | |
| Q3 2020 | +5.2% | +1.3% | +11.7% | |
| Q2 2020 | +4.3% | -1.9% | +11.6% | |
| Q1 2020 | +9.0% | +6.5% | +21.4% | |
| Q4 2019 | +0.4% | -9.5% | -17.0% | |
| Q3 2019 | -31.4% | -15.5% | -7.0% | |
| Q2 2019 | -24.7% | -26.2% | -37.2% | |
| Q1 2019 | -1.9% | -4.7% | -9.4% | |
| Q4 2018 | -4.3% | -2.1% | +1.6% | |
| Q3 2018 | -4.1% | -5.3% | -3.5% | |
| Q2 2018 | +2.8% | -3.1% | +3.3% | |
| Q1 2018 | +2.8% | +7.5% | +18.7% | |
| Q4 2017 | -2.1% | -5.1% | -3.3% | |
| Q3 2017 | -9.7% | -11.0% | +4.6% | |
| Q2 2017 | +4.8% | +5.5% | +4.6% | |
| Q1 2017 | +8.2% | +8.2% | +11.6% | |
| Q4 2016 | +5.9% | +4.8% | +0.0% | |
| Q3 2016 | -5.0% | -5.0% | +5.2% | |
| Q2 2016 | +6.1% | +6.7% | +6.5% | |
| Q1 2016 | +2.5% | — | — | |
| Q4 2015 | -2.8% | — | — | |
| Q3 2015 | -27.3% | — | — | |
| Q2 2015 | +10.7% | — | — | |
| Q1 2015 | +9.5% | — | — | |
| Q4 2014 | +7.7% | — | — | |
| Q3 2014 | +16.5% | — | — | |
| Q2 2014 | -14.4% | — | — | |
| Q1 2014 | -5.4% | — | — | |
| Q4 2013 | +1.2% | — | — | |
| Q3 2013 | +15.4% | — | — | |
| Q2 2013 | +7.6% | — | — | |
| Q1 2013 | -13.9% | — | — | |
| Q4 2012 | -14.7% | — | — | |
| Q3 2012 | -2.8% | — | — | |
| Q2 2012 | -0.5% | — | — | |
| Q1 2011 | -0.7% | — | — | |
| Q4 2011 | -0.7% | — | — | |
| Q1 2012 | +1.1% | — | — | |
| Q1 2010 | -1.6% | — | — | |
| Q4 2009 | -1.6% | — | — | |
| Q3 2010 | -1.1% | — | — | |
| Q3 2011 | -1.1% | — | — | |
| Q2 2011 | +1.6% | — | — | |
| Q2 2010 | +1.6% | — | — | |
| Q4 2010 | +1.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro